Theresa Borgia, MBA
About Theresa Borgia, MBA
Theresa Borgia, MBA, is the Account Vice President, Life Sciences at Komodo Health in the New York City Metropolitan Area, with extensive experience in market research and client solutions.
Current Company
Theresa Borgia is currently employed at Komodo Health as the Account Vice President for Life Sciences. She operates in the New York City Metropolitan Area, where she is responsible for managing several key accounts. Her role includes launching services, negotiating deals, and providing strategic recommendations that contribute to the company's growth and revenue.
Professional Title
Theresa Borgia holds the title of Account Vice President, Life Sciences at Komodo Health. In this capacity, she plays a pivotal role in driving business strategies and managing client relationships within the life sciences sector.
Education and Expertise
Theresa Borgia earned her MBA with a concentration in Market Research Insights and Analytics from Rutgers University - Newark. She also holds a Bachelor of Arts degree in Economics and Psychology from Drew University. Her educational background has fortified her expertise in market research, client consulting, and strategic business solutions.
Previous Experience
Theresa Borgia has amassed extensive experience throughout her career. She served as Head of Market Research and Insights at Zitter Insights, part of MMIT, and held the position of Vice President, Client Solutions at Symphony Advanced Media. At Ipsos, she was the Senior Vice President, Innoquest and the North American Lead for Bayer Healthcare. At Nielsen, she held multiple roles over the years, including Vice President & Client Business Partner for Johnson & Johnson and Region Manager for the BASES Parsippany office.
Achievements and Business Impact
Theresa Borgia has achieved significant milestones in her career. At Komodo Health, she launched the Payer Rapid Response service and negotiated a global three-year deal, securing 'preferred supplier' status. Her strategic recommendations have led to substantial revenue growth, including an additional $30M in sales for an Rx to OTC switch and an extra $100k project by addressing client concerns. As Region Manager at Nielsen, she exceeded revenue and margin targets, growing revenue by 45%, or $7M, year-over-year.